Metabotropic glutamate antagonists alone and in combination with morphine: Comparison across two models of acute pain and a model of persistent, inflammatory pain

Behavioural Pharmacology

Volumn 22, Issue 8, 2011, Pages 785-793

  Picker, Mitchell J ^a   Daugherty, Dana ^a   Henry, Fredrick E ^a   Miller, Laurence L ^a,b   Dykstra, Linda A ^a  

^a University of North Carolina at Chapel Hill   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

2 methyl 6 phenylethynylpyridine; acute pain; capsaicin; JNJ16259685; metabotropic glutamate antagonists; morphine; persistent pain; potentiation; rat

Indexed keywords

2 METHYL 6 PHENYLETHYNYLPYRIDINE; CAPSAICIN; JNJ 16259685; METABOTROPIC RECEPTOR 1; METABOTROPIC RECEPTOR 5; METABOTROPIC RECEPTOR ANTAGONIST; MORPHINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG POTENTIATION; HOT PLATE TEST; MALE; MONOTHERAPY; NONHUMAN; PAIN; RAT;

ANIMALS; BEHAVIOR, ANIMAL; CAPSAICIN; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; EXCITATORY AMINO ACID ANTAGONISTS; INFLAMMATION; MALE; MORPHINE; NARCOTICS; PAIN; PAIN MEASUREMENT; PYRIDINES; QUINOLINES; RATS; RATS, INBRED F344; RECEPTORS, METABOTROPIC GLUTAMATE;

EID: 80855130498     PISSN: 09558810     EISSN: 14735849     Source Type: Journal    
DOI: 10.1097/FBP.0b013e32834d13a2     Document Type: Article

References (47)

1. Allen RM, Granger AL, Dykstra LA (2003). The competitive N-methyl-D-aspartate receptor antagonist (-)-6-phosphonomethyl-deca- hydroisoquinoline-3-car-boxylic acid (LY235959) potentiates the antinociceptive effects of opioids that vary in efficacy at the m-opioid receptor. J Pharmacol Exp Ther 307: 785-792. (Pubitemid 37310696)
2. Alvarez FJ, Villalba RM, Carr PA, Grandes P, Somohano PM (2000). Differential distribution of metabotropic glutamate receptors 1a, 1b, and 5 in the rat spinal cord. J Comp Neurol 422:464-487.
3. Barrett AC, Smith ES, Picker MJ (2003). Capsaicin-induced hyperalgesia and mu-opioid-induced antihyperalgesia in male and female Fischer344 rats. J Pharmacol Exp Ther 307:237-245. (Pubitemid 37151913)
4. Chaplan SR, Malmberg AB, Yaksh TL (1997). Efficacy of spinal NMDA receptor antagonism in formalin hyperalgesia and nerve injury evoked allodynia in the rat. J Pharmacol Exp Ther 280:829-838. (Pubitemid 27171346)
5. Chen SL, Huang EY, Chow LH, Tao PL (2005). Dextromethorphan differentially effects opioid antinociception in rats. Br J Pharmacol 144:400-404. (Pubitemid 40313687)
6. Cosford ND, Tehrani L, Roppe J (2003). 3-[(2-Methyl-1,3-thiazol-4-yl) ethynyl] pyridine: a potent and highly selective metabotropic glutamate receptor subtype 5 antagonist with anxiolytic activity. J Med Chem 46:204-206. (Pubitemid 36078139)
7. Craft RM, Lee D (2005). NMDA antagonist modulation of morphine antinocicep-tion in female vs. male rats. Pharmacol Biochem Behav 80:639-649. (Pubitemid 41583213)
8. Dolan S, Kelly JG, Monteiro AM, Nolan AM (2003). Up-regulation of metabotropic glutamate receptor subtypes 3 and 5 in spinal cord in a clinical model of persistent inflammation and hyperalgesia. Pain 106:501-512. (Pubitemid 37505899)
9. El-Kouhen O, Lehto SG, Pan JB, Chang R, Baker SJ, Zhong C, et al. (2006). Blockade of mGluR1 receptor results in analgesia and disruption of motor and cognitive performances: effects of A-841720, a novel non-competitive mGluR1 receptor antagonist. Br J Pharmacol 149:761-774. (Pubitemid 44748069)
10. Fischer BD, Dykstra LA (2006). Interactions between an NMDA antagonist and low-efficacy opioid receptor agonists in assays of schedule-controlled responding and thermal nociception. J Pharmacol Exp Ther 318: 1300-1306. (Pubitemid 44268339)
11. Fischer BD, Miller LL, Henry FE, Picker MJ, Dykstra LA (2008a). Increased efficacy of m-opioid agonist-induced antinociception by metabotropic glutamate receptor antagonists: comparison with (-)-6-phosphonomethyl-deca- hydroisoquinoline-3-carboxylic acid (LY235959). Psychopharmacology 198:271-278.
12. Fischer BD, Zimmerman EI, Picker MJ, Dykstra LA (2008b). Morphine in combination with metabotropic glutamate receptor antagonists on schedule-controlled responding and thermal nociception. J Pharmacol Exp Ther 324:732-739. (Pubitemid 351185828)
13. Fundytus ME, Yashpal K, Chabot JG, Osborne MG, Lefebvre CD, Dray A, et al. (2001). Knockdown of spinal metabotropic glutamate receptor 1 (mGluR(1)) alleviates pain and restores opioid efficacy after nerve injury in rats. Br J Pharmacol 132:354-367. (Pubitemid 32128467)
14. Galer BS, Lee D, Ma T, Nagle B, Schlagheck TG (2005). MorphiDex (morphine sulfate/dextromethorphan hydrobromide combination) in the treatment of chronic pain: three multicenter, randomized, double-blind, controlled clinical trials fail to demonstrate enhanced opioid analgesia or reduction intolerance. Pain 115:284-295. (Pubitemid 40725285)
15. Henry SA, Lehmann-Masten V, Gasparini F, Geyer MA, Markou A (2002). The mGluR5 antagonist MPEP, but not the mGluR2/3 agonist LY314582, augments PCP effects on prepulse inhibition and locomotor activity. Neuropharmacology 43:1199-1209. (Pubitemid 36084431)
16. Hodgson RA, Hydea LA, Guthriea DH, Cohen-Williams ME, Leach PT, Kazdobaa TM, et al. (2011). Characterization of the selective mGluR1 antagonist, JNJ16259685, in rodent models of movement and coordination. Pharmacol Biochem Behav 98:181-187.
17. Jesse CR, Jucielli S, Cristina W, Nogueira CW (2008). Effect of a metabotropic glutamate receptor 5 antagonist, MPEP, on the nociceptive response induced by intrathecal injection of excitatory aminoacids, substance P, bradykinin or cytokines in mice. Pharmacol Biochem Behav 90:608-613.
18. Jia H, Rustioni A, Valtschanoff JG (1999). Metabotropic glutamate receptors in superficial laminae of the rat dorsal horn. J Comp Neurol 410:627-642. (Pubitemid 29316073)
19. Katz NP (2000). MorphiDex (MS:DM) double-blind, multiple-dose studies in chronic pain patients. J Pain Symptom Manage 19:S37-S41.
20. Kayser V, Elfassi IE, Aubel B, Melfort M, Julius D, Gingrich JA (2007). Mechanical, thermal and formalin-induced nociception is differentially altered in 5-HT1A-/-, 5-HT1B-/-, 5-HT2A-/-, 5-HT3A-/-and 5-HTT-/-knockout male mice. Pain 130:235-248. (Pubitemid 46994702)
21. Kelso SR, Nelson TE, Leonard JP (1992). Protein kinase C-mediated enhancement of NMDA currents by metabotropic glutamate receptors in Xenopus oocytes. J Physiol 449:705-718.
22. Kohara A, Nagakura Y, Kiso T, Toya T, Watabiki T, Tamura S, et al. (2007). Antinociceptive profile of a selective metabotropic glutamate receptor 1 antagonist YM-230888 in chronic pain rodent models. Eur J Pharmacol 571:8-16. (Pubitemid 47284045)
23. Kozela E, Pilc A, Popik P (2003). Inhibitory effects of MPEP, an mGluR5 antagonist, and memantine, an N-methyl-D-aspartate receptor antagonist, on morphine antinociceptive tolerance in mice. Psychopharmacology 165:245-251. (Pubitemid 36197599)
24. Lao LJ, Song B, Marvizón JCG (2003). Neurokinin release produced by capsaicin acting on the central terminals and axons of primary afferents: relationship with n-methyl-aspartate and gabab receptors. Neuroscience 121:667-680. (Pubitemid 38367506)
25. Lea PM IV, Faden AI (2006). Metabotropic glutamate receptor subtype 5 antagonists MPEP and MTEP. CNS Drug Rev 12:149-166. (Pubitemid 44300382)
26. Le Bars D, Gozariu M, Cadden SW (2001). Animal models of nociception. Pharmacol Rev 53:597-652. (Pubitemid 33136239)
27. Lee HJ, Choi HS, Ju JS, Bae YC, Kim SK, Yoon YW, Ahn DK (2006). Peripheral mGluR5 antagonist attenuated craniofacial muscle pain and inflammation but not mGluR1 antagonist in highly anesthetized rats. Brain Res Bull 70:378-385. (Pubitemid 44486568)
28. Lomas LM, Terner JM, Picker MJ (2008). Sex differences in NMDA antagonist enhancement of morphine-antihyperalgesia in a capsaicin model of persistent pain: comparisons to two models of acute pain. Pharmacol Biochem Behav 89:127-136.
29. Maeda T, Kishioka S, Fan X, Fukazawa Y, Shimizu N, Ozaki M, Yamamoto H (2002). Effects of diltiazem and MK-801 on morphine analgesia and pharmacokinetics in mice. Neurosci Lett 326:216-218. (Pubitemid 34722462)
30. Mao J (1999). NMDA and opioid receptors: their interactions in antinociception, tolerance and neuroplasticity. Brain Res Brain Res Rev 30:289-304. (Pubitemid 29531489)
31. Mao J, Price DD, Mayer DJ, Lu J, Hayes RL (1992). Intrathecal MK-801 and local nerve anesthesia synergistically reduce nociceptive behaviors in rats with experimental peripheral mononeuropathy. Brain Res 576:254-262.
32. Nemmani KVS, Grisel JE, Stowe JR, Smith-Carliss R, Mogil JS (2004). Modulation of morphine analgesia by site-specific N-methyl-D-aspartate receptor antagonists: dependence on sex, site of antagonism, morphine dose, and time. Pain 109:274-283. (Pubitemid 38638704)
33. Osikowicz M, Mika J, Makuch W, Przewlocka B (2008). Glutamate receptor ligands attenuate allodynia and hyperalgesia and potentiate morphine effects in a mouse model of neuropathic pain. Pain 139:117-126.
34. Popik P, Wrobel M (2002). Morphine conditioned reward is inhibited by MPEP, the mGluR5 antagonist. Neuropharmacology 43:1210-1217. (Pubitemid 36084432)
35. Sakurada R, Wako K, Sguiyama A, Sakurada C, Tan-Ho K, Kisara K (1998). Involvement of spinal NMDA receptors in capsaicin-induced nociception. Pharmacol Biochem Behav 59:339-345. (Pubitemid 28072726)
36. Schröder H, Wu DF, Seifert A, Rankovic M, Schulz S, Höllt V, Koch T (2009). Allosteric modulation of metabotropic glutamate receptor 5 affects phos-phorylation, internalization, and desensitization of the m-opioid receptor. Neuropharmacology 56:768-778.
37. Sevostianova N, Danysz W (2006). Analgesic effects of mGlu1 and mGlu5 receptor antagonists in the rat formalin test. Neuropharmacology 51: 623-630. (Pubitemid 44215967)
38. Simmons RMA, Webster AA, Kalra AB, Iyengar S (2002). Group II mGluR receptor agonists are effective in persistent and neuropathic pain models in rats. Pharmacol Biochem Behav 73:419-427. (Pubitemid 34765579)
39. Siniscalcoa D, Giordanoa C, Fuccioa C, Luongoa L, Ferraracciob F, Rossia F, et al. (2008). Involvement of subtype 1 metabotropic glutamate receptors in apoptosis and caspase-7 over-expression in spinal cord of neuropathic rats. Pharmacol Res 57:223-233.
40. Skeberdis VA, Lan J, Opitz T, Zheng X, Bennett MV, Zukin RS (2001). mGluR1-mediated potentiation of NMDA-receptors in involves a rise in intracellular calcium and activation of protein kinase C. Neuropharmacology 40: 856-865. (Pubitemid 32510799)
41. Soliman AC, Yu JSC, Coderre TJ (2004). mGlu and NMDA receptor contributions to capsaicin-induced thermal and mechanical hypersensitivity. Neuropharma-cology 48:325-332. (Pubitemid 40249995)
42. Tallarida RJ, Murray RB (1987). Manual of pharmacologic calculations with computer programs. Berlin: Springer.
43. Walker K, Bowes M, Pansear M, Davis A, Gentry C, Kesingland A, et al. (2001a). Metabotropic glutamate receptor subtype 5 (mGlu5) and nociceptive function I: selective blockade of mGlu5 receptors in models of acute, persistent and chronic pain. Neuropharmacology 40:1-9. (Pubitemid 33779794)
44. Walker K, Reeve A, Bowes M, Winter J, Witherspoon G, Davis A, et al. (2001b). mGlu5 receptors and nociceptive function II: mGlu5 receptors functionally expressed on peripheral sensory neurons mediate inflammatory hyperalgesia. Neuropharmacology 40:10-19. (Pubitemid 33779795)
45. Yang D, Gereau RW (2002). Peripheral group II metabotropic glutamate receptors (mGlu2/3) regulate prostaglandin E2-mediated sensitization of capsaicin responses and thermal nociception. J Neurosci 22:6388-6393. (Pubitemid 35386394)
46. Yoon MH, Choi J, Bae HB, Kim SJ, Chung ST, Jeong SW, et al. (2006). Antinociceptive effects and synergistic interaction with morphine of intrathecal metabotropic glutamate receptor 2/3 antagonist in the formalin test of rats. Neurosci Lett 394:222-226. (Pubitemid 43144854)
47. Zhu CZ, Wilson SG, Mikusa JP (2004). Assessing the role of metabotropic glutamate receptor 5 in multiple nociceptive modalities. Eur J Pharmacol 506:107-118. (Pubitemid 39592907)